These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis]. Takasaki Y Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839 [No Abstract] [Full Text] [Related]
6. New therapies for systemic lupus erythematosus: cellular targets. Looney RJ; Anolik J; Sanz I Rheum Dis Clin North Am; 2006 Feb; 32(1):201-15, xi. PubMed ID: 16504831 [TBL] [Abstract][Full Text] [Related]
7. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Vallerskog T; Gunnarsson I; Widhe M; Risselada A; Klareskog L; van Vollenhoven R; Malmström V; Trollmo C Clin Immunol; 2007 Jan; 122(1):62-74. PubMed ID: 17046329 [TBL] [Abstract][Full Text] [Related]
9. B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE. Iwata S; Saito K; Tokunaga M; Tanaka Y Ann Rheum Dis; 2012 Oct; 71(10):1749-50. PubMed ID: 22586167 [No Abstract] [Full Text] [Related]
10. B cells in SLE: different biological drugs for different pathogenic mechanisms. Diamanti AP; Rosado MM; Carsetti R; Valesini G Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325 [TBL] [Abstract][Full Text] [Related]
11. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies. Sousa E; Isenberg D Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785 [TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus in children: current and emerging therapies. Macdermott EJ; Adams A; Lehman TJ Lupus; 2007; 16(8):677-83. PubMed ID: 17711907 [TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus. Goldblatt F; Isenberg DA Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946 [TBL] [Abstract][Full Text] [Related]
17. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports. Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745 [TBL] [Abstract][Full Text] [Related]
18. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423 [TBL] [Abstract][Full Text] [Related]
19. Origin and significance of autoantibodies. Dighiero G; Kaushik A; Poncet P; Ge XR Concepts Immunopathol; 1987; 4():42-76. PubMed ID: 3297339 [No Abstract] [Full Text] [Related]
20. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case. Uthman I; Taher A; Abbas O; Menassa J; Ghosn S Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821 [No Abstract] [Full Text] [Related] [Next] [New Search]